Octreotide acetate
HealthData.Gov
Updated Mar 25, 2026
About this dataset
Octreotide Acetate is a generic prescription injectable medication, available in strengths of 200 mcg/mL and 1 mg/mL, used for intravenous or subcutaneous administration. It acts as a somatostatin analog to help manage certain hormonal conditions. Manufactured by Hikma Pharmaceuticals USA Inc. under ANDA076330. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Octreotide acetate
Access the FDA dataset for Octreotide acetate — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025